Publication > Page 72
  • Leukemia  ·  December 2, 2016

    Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial.

    Edelmann J, Tausch E, Landau DA, Robrecht S, Bahlo J, Fischer K, Fink AM, Bloehdorn J, Holzmann K, Böttcher S, Werner L, Kneba M, Gribben JG, Neuberg DS, Wu CJ, Hallek M, Döhner H, Stilgenbauer S.

    link out icon
  • Nucleic Acid Res  ·  November 29, 2016

    Pharos: Collating protein information to shed light on the druggable genome.

    Nguyen DT, Mathias S, Bologa C, Brunak S, Fernandez N, Gaulton A, Hersey A, Holmes J, Jensen LJ, Karlsson A, Liu G, Ma’ayan A, Mandava G, Mani S, Mehta S, Overington J, Patel J, Rouillard AD, Schürer S, Sheils T, Simeonov A, Sklar LA, Southall N, Ursu O, Vidovic D, Waller A, Yang J, Jadhav A, Oprea TI, Guha R.

    link out icon
  • J Exp Med  ·  November 18, 2016

    Human dendritic cells (DCs) are derived from distinct circulating precursors that are precommitted to become CD1c+ or CD141+ DCs.

    Breton G, Zheng S, Valieris R, Tojal da Silva I, Satija R, Nussenzweig MC.

    link out icon
  • Clin Med Insights Oncol  ·  November 15, 2016

    Key Difficulties Associated with Cancer Biology.

    Fang X, Aragon-Ching J, Cidon EU.

    link out icon
  • Cancer Cell  ·  November 14, 2016

    Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia.

    Wang L, Brooks AN, Fan J, Wan Y, Gambe R, Li S, Hergert S, Yin S, Freeman SS, Levin JZ, Fan L, Seiler M, Buonamici S, Smith PG, Chau KF, Cibulskis CL, Zhang W, Rassenti LZ, Ghia EM, Kipps TJ, Fernandes S, Bloch DB, Kotliar D, Landau DA, Shukla SA, Aster JC, Reed R, DeLuca DS, Brown JR, Neuberg D, Getz G, Livak KJ, Meyerson MM, Kharchenko PV, Wu CJ.

    link out icon
  • ScienceDirect  ·  November 14, 2016

    Concerted Genetic Function in Blood Traits

    Lappalainen T, Hemmluth-Kim S.

    link out icon
  • Nature  ·  October 22, 2016

    Mutations driving CLL and their evolution in progression and relapse.

    Landau DA, Tausch E, Taylor-Weiner AN, Stewart C, Reiter JG, Bahlo J, Kluth S, Bozic I, Lawrence M, Böttcher S, Carter SL, Cibulskis K, Mertens D, Sougnez CL, Rosenberg M, Hess JM, Edelmann J, Kless S, Kneba M, Ritgen M, Fink A, Fischer K, Gabriel S, Lander ES, Nowak MA, Döhner H, Hallek M, Neuberg D, Getz G, Stilgenbauer S, Wu CJ.

    link out icon
  • Bioinformatics  ·  October 15, 2016

    Conpair: concordance and contamination estimator for matched tumor-normal pairs.

    Bergmann EA, Chen BJ, Arora K, Vacic V, Zody MC.

    link out icon
  • Br J Dermatol  ·  October 8, 2016

    Immunohistochemical analysis of T-type calcium channels in acquired melanocytic nevi and melanoma.

    Maiques O, Macià A, Moreno S, Barceló C, Santacana M, Vea A, Herreros J, Gatius S, Ortega E, Valls J, Chen BJ, Llobet-Navas D, Matias-Guiu X, Cantí C, Marti RM.

    link out icon
  • Science  ·  June 2, 2016

    The Genome Project-Write

    Boeke JD, Church G, Hessel A, Kelley NJ, Arkin A, Cai Y, Carlson R, Chakravarti A, Cornish VW, Holt L, Isaacs FJ, Kuiken T, Lajoie M, Lessor T, Lunshof J, Maurano MT, Mitchell LA, Rine J, Rosser S, Sanjana NE, Silver PA, Valle D, Wang H, Way JC, Yang L.

    link out icon
Decorative image color fade left Decorative image color fade right Decorative image color fade